English
简体中文
Total: £ 56.28
Published Date: 2025-09-25 | Pages: 98 | Tables: 97 | Pharma & Healthcare
The global Pets Anti-infective Drugs market size was US$ 2111 million in 2024 and is forecast to a readjusted size of US$ 6233 million by 2031 with a CAGR of 17.0% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Pets Anti-infective Drugs market competitiveness, regional economic performance, and supply chain configurations.
Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
The pet anti-infective drug market is a growing area. With the expansion of the global pet market and the improvement of pet health awareness, this market has shown great development potential.
The pet anti-infective drug market is dominated by many well-known companies, such as Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products and Ceva Santé Animale, which have deep technical accumulation and market experience in veterinary drug research and development, production and market operation.
The market concentration is high, and a few companies occupy a large market share, but with the entry of new companies and the intensification of market competition, the market pattern may change.
Pet anti-infective drugs mainly include antibiotics, antibacterial drugs and other types, which are used to prevent and treat various bacterial infections of pets. These drugs play an important role in improving the quality of life of pets and prolonging their lifespan.
With the advancement of science and technology and the increase in R&D investment, new products and new therapies will continue to emerge in the pet anti-infective drug market. These innovative products will have better efficacy, lower side effects and higher safety, meeting the diverse needs of pet owners.
With the development of precision medicine, the pet anti-infective drug market will pay more attention to personalized treatment in the future. Providing customized anti-infection treatment plans for pets of different types, ages, and health conditions will become an important direction for market development.
The global Pets Anti-infective Drugs market is strategically segmented by company, region (country), by Administration Method, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Administration Method, and by Application for 2020-2031.
Market Segmentation
By Company:
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook
Hanvet Pet Health
Wuhan Hvsen Biotechnology
Zhejiang Hisun Animal Healthcare Products
By Type: (Dominant Segment vs High-Margin Innovation)
External Use
Internal Use
Injection
By Application: (Core Demand Driver vs Emerging Opportunity)
Dog
Cat
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Zoetis in Europe)
- Emerging Product Trends: External Use adoption vs. Internal Use premiumization
- Demand-Side Dynamics: Dog growth in China vs. Cat potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Brazil
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pets Anti-infective Drugs market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Internal Use in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cat in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., External Use dominance in Europe vs. Internal Use demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Pets Anti-infective Drugs Product Scope
1.2 Pets Anti-infective Drugs by Administration Method
1.2.1 Global Pets Anti-infective Drugs Sales by Administration Method (2020 & 2024 & 2031)
1.2.2 External Use
1.2.3 Internal Use
1.2.4 Injection
1.3 Pets Anti-infective Drugs by Application
1.3.1 Global Pets Anti-infective Drugs Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Global Pets Anti-infective Drugs Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pets Anti-infective Drugs Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pets Anti-infective Drugs Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pets Anti-infective Drugs Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pets Anti-infective Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pets Anti-infective Drugs Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pets Anti-infective Drugs Sales Market Share by Region (2020-2025)
2.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Region (2020-2025)
2.3 Global Pets Anti-infective Drugs Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pets Anti-infective Drugs Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pets Anti-infective Drugs Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Pets Anti-infective Drugs Market Size and Prospective (2020-2031)
2.4.2 Europe Pets Anti-infective Drugs Market Size and Prospective (2020-2031)
2.4.3 China Pets Anti-infective Drugs Market Size and Prospective (2020-2031)
2.4.4 Brazil Pets Anti-infective Drugs Market Size and Prospective (2020-2031)
3 Global Market Size by Administration Method
3.1 Global Pets Anti-infective Drugs Historic Market Review by Administration Method (2020-2025)
3.1.1 Global Pets Anti-infective Drugs Sales by Administration Method (2020-2025)
3.1.2 Global Pets Anti-infective Drugs Revenue by Administration Method (2020-2025)
3.1.3 Global Pets Anti-infective Drugs Price by Administration Method (2020-2025)
3.2 Global Pets Anti-infective Drugs Market Estimates and Forecasts by Administration Method (2026-2031)
3.2.1 Global Pets Anti-infective Drugs Sales Forecast by Administration Method (2026-2031)
3.2.2 Global Pets Anti-infective Drugs Revenue Forecast by Administration Method (2026-2031)
3.2.3 Global Pets Anti-infective Drugs Price Forecast by Administration Method (2026-2031)
3.3 Different Types Pets Anti-infective Drugs Representative Players
4 Global Market Size by Application
4.1 Global Pets Anti-infective Drugs Historic Market Review by Application (2020-2025)
4.1.1 Global Pets Anti-infective Drugs Sales by Application (2020-2025)
4.1.2 Global Pets Anti-infective Drugs Revenue by Application (2020-2025)
4.1.3 Global Pets Anti-infective Drugs Price by Application (2020-2025)
4.2 Global Pets Anti-infective Drugs Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pets Anti-infective Drugs Sales Forecast by Application (2026-2031)
4.2.2 Global Pets Anti-infective Drugs Revenue Forecast by Application (2026-2031)
4.2.3 Global Pets Anti-infective Drugs Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pets Anti-infective Drugs Application
5 Competition Landscape by Players
5.1 Global Pets Anti-infective Drugs Sales by Players (2020-2025)
5.2 Global Top Pets Anti-infective Drugs Players by Revenue (2020-2025)
5.3 Global Pets Anti-infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets Anti-infective Drugs as of 2024)
5.4 Global Pets Anti-infective Drugs Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pets Anti-infective Drugs, Product Type & Application
5.7 Global Key Manufacturers of Pets Anti-infective Drugs, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pets Anti-infective Drugs Sales by Company
6.1.1.1 North America Pets Anti-infective Drugs Sales by Company (2020-2025)
6.1.1.2 North America Pets Anti-infective Drugs Revenue by Company (2020-2025)
6.1.2 North America Pets Anti-infective Drugs Sales Breakdown by Administration Method (2020-2025)
6.1.3 North America Pets Anti-infective Drugs Sales Breakdown by Application (2020-2025)
6.1.4 North America Pets Anti-infective Drugs Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pets Anti-infective Drugs Sales by Company
6.2.1.1 Europe Pets Anti-infective Drugs Sales by Company (2020-2025)
6.2.1.2 Europe Pets Anti-infective Drugs Revenue by Company (2020-2025)
6.2.2 Europe Pets Anti-infective Drugs Sales Breakdown by Administration Method (2020-2025)
6.2.3 Europe Pets Anti-infective Drugs Sales Breakdown by Application (2020-2025)
6.2.4 Europe Pets Anti-infective Drugs Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pets Anti-infective Drugs Sales by Company
6.3.1.1 China Pets Anti-infective Drugs Sales by Company (2020-2025)
6.3.1.2 China Pets Anti-infective Drugs Revenue by Company (2020-2025)
6.3.2 China Pets Anti-infective Drugs Sales Breakdown by Administration Method (2020-2025)
6.3.3 China Pets Anti-infective Drugs Sales Breakdown by Application (2020-2025)
6.3.4 China Pets Anti-infective Drugs Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Brazil Market: Players, Segments, Downstream and Major Customers
6.4.1 Brazil Pets Anti-infective Drugs Sales by Company
6.4.1.1 Brazil Pets Anti-infective Drugs Sales by Company (2020-2025)
6.4.1.2 Brazil Pets Anti-infective Drugs Revenue by Company (2020-2025)
6.4.2 Brazil Pets Anti-infective Drugs Sales Breakdown by Administration Method (2020-2025)
6.4.3 Brazil Pets Anti-infective Drugs Sales Breakdown by Application (2020-2025)
6.4.4 Brazil Pets Anti-infective Drugs Major Customer
6.4.5 Brazil Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Zoetis Pets Anti-infective Drugs Products Offered
7.1.5 Zoetis Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Business Overview
7.2.3 Merck Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Merck Pets Anti-infective Drugs Products Offered
7.2.5 Merck Recent Development
7.3 Elanco
7.3.1 Elanco Company Information
7.3.2 Elanco Business Overview
7.3.3 Elanco Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Elanco Pets Anti-infective Drugs Products Offered
7.3.5 Elanco Recent Development
7.4 Virbac
7.4.1 Virbac Company Information
7.4.2 Virbac Business Overview
7.4.3 Virbac Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Virbac Pets Anti-infective Drugs Products Offered
7.4.5 Virbac Recent Development
7.5 Dechra Veterinary Products
7.5.1 Dechra Veterinary Products Company Information
7.5.2 Dechra Veterinary Products Business Overview
7.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Products Offered
7.5.5 Dechra Veterinary Products Recent Development
7.6 Ceva Santé Animale
7.6.1 Ceva Santé Animale Company Information
7.6.2 Ceva Santé Animale Business Overview
7.6.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ceva Santé Animale Pets Anti-infective Drugs Products Offered
7.6.5 Ceva Santé Animale Recent Development
7.7 Vetoquinol
7.7.1 Vetoquinol Company Information
7.7.2 Vetoquinol Business Overview
7.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Vetoquinol Pets Anti-infective Drugs Products Offered
7.7.5 Vetoquinol Recent Development
7.8 Nanjing Jindun Animal
7.8.1 Nanjing Jindun Animal Company Information
7.8.2 Nanjing Jindun Animal Business Overview
7.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Products Offered
7.8.5 Nanjing Jindun Animal Recent Development
7.9 Wuhan Chopperlvya
7.9.1 Wuhan Chopperlvya Company Information
7.9.2 Wuhan Chopperlvya Business Overview
7.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Products Offered
7.9.5 Wuhan Chopperlvya Recent Development
7.10 Bimeda Animal Health
7.10.1 Bimeda Animal Health Company Information
7.10.2 Bimeda Animal Health Business Overview
7.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Bimeda Animal Health Pets Anti-infective Drugs Products Offered
7.10.5 Bimeda Animal Health Recent Development
7.11 Ouro Fino Saude
7.11.1 Ouro Fino Saude Company Information
7.11.2 Ouro Fino Saude Business Overview
7.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Ouro Fino Saude Pets Anti-infective Drugs Products Offered
7.11.5 Ouro Fino Saude Recent Development
7.12 Norbrook
7.12.1 Norbrook Company Information
7.12.2 Norbrook Business Overview
7.12.3 Norbrook Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Norbrook Pets Anti-infective Drugs Products Offered
7.12.5 Norbrook Recent Development
7.13 Hanvet Pet Health
7.13.1 Hanvet Pet Health Company Information
7.13.2 Hanvet Pet Health Business Overview
7.13.3 Hanvet Pet Health Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Hanvet Pet Health Pets Anti-infective Drugs Products Offered
7.13.5 Hanvet Pet Health Recent Development
7.14 Wuhan Hvsen Biotechnology
7.14.1 Wuhan Hvsen Biotechnology Company Information
7.14.2 Wuhan Hvsen Biotechnology Business Overview
7.14.3 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Products Offered
7.14.5 Wuhan Hvsen Biotechnology Recent Development
7.15 Zhejiang Hisun Animal Healthcare Products
7.15.1 Zhejiang Hisun Animal Healthcare Products Company Information
7.15.2 Zhejiang Hisun Animal Healthcare Products Business Overview
7.15.3 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Products Offered
7.15.5 Zhejiang Hisun Animal Healthcare Products Recent Development
8 Pets Anti-infective Drugs Manufacturing Cost Analysis
8.1 Pets Anti-infective Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pets Anti-infective Drugs
8.4 Pets Anti-infective Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pets Anti-infective Drugs Distributors List
9.3 Pets Anti-infective Drugs Customers
10 Pets Anti-infective Drugs Market Dynamics
10.1 Pets Anti-infective Drugs Industry Trends
10.2 Pets Anti-infective Drugs Market Drivers
10.3 Pets Anti-infective Drugs Market Challenges
10.4 Pets Anti-infective Drugs Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Pets Anti-infective Drugs Sales (US$ Million) Growth Rate by Administration Method (2020 & 2024 & 2031)
Table 2. Global Pets Anti-infective Drugs Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Pets Anti-infective Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pets Anti-infective Drugs Sales (K Units) by Region (2020-2025)
Table 5. Global Pets Anti-infective Drugs Sales Market Share by Region (2020-2025)
Table 6. Global Pets Anti-infective Drugs Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Pets Anti-infective Drugs Revenue Share by Region (2020-2025)
Table 8. Global Pets Anti-infective Drugs Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Pets Anti-infective Drugs Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Pets Anti-infective Drugs Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Pets Anti-infective Drugs Revenue Share Forecast by Region (2026-2031)
Table 12. Global Pets Anti-infective Drugs Sales by Administration Method (K Units) & (2020-2025)
Table 13. Global Pets Anti-infective Drugs Sales Share by Administration Method (2020-2025)
Table 14. Global Pets Anti-infective Drugs Revenue by Administration Method (US$ Million) & (2020-2025)
Table 15. Global Pets Anti-infective Drugs Price by Administration Method (US$/Unit) & (2020-2025)
Table 16. Global Pets Anti-infective Drugs Sales by Administration Method (K Units) & (2026-2031)
Table 17. Global Pets Anti-infective Drugs Revenue by Administration Method (US$ Million) & (2026-2031)
Table 18. Global Pets Anti-infective Drugs Price by Administration Method (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Pets Anti-infective Drugs Sales by Application (K Units) & (2020-2025)
Table 21. Global Pets Anti-infective Drugs Sales Share by Application (2020-2025)
Table 22. Global Pets Anti-infective Drugs Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Pets Anti-infective Drugs Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Pets Anti-infective Drugs Sales by Application (K Units) & (2026-2031)
Table 25. Global Pets Anti-infective Drugs Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Pets Anti-infective Drugs Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Pets Anti-infective Drugs Application
Table 28. Global Pets Anti-infective Drugs Sales by Company (K Units) & (2020-2025)
Table 29. Global Pets Anti-infective Drugs Sales Share by Company (2020-2025)
Table 30. Global Pets Anti-infective Drugs Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Pets Anti-infective Drugs Revenue Share by Company (2020-2025)
Table 32. Global Pets Anti-infective Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets Anti-infective Drugs as of 2024)
Table 33. Global Market Pets Anti-infective Drugs Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Pets Anti-infective Drugs, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Pets Anti-infective Drugs, Product Type & Application
Table 36. Global Key Manufacturers of Pets Anti-infective Drugs, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Pets Anti-infective Drugs Sales by Company (2020-2025) & (K Units)
Table 39. North America Pets Anti-infective Drugs Sales Market Share by Company (2020-2025)
Table 40. North America Pets Anti-infective Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Pets Anti-infective Drugs Revenue Market Share by Company (2020-2025)
Table 42. North America Pets Anti-infective Drugs Sales by Administration Method (2020-2025) & (K Units)
Table 43. North America Pets Anti-infective Drugs Sales Market Share by Administration Method (2020-2025)
Table 44. North America Pets Anti-infective Drugs Sales by Application (2020-2025) & (K Units)
Table 45. North America Pets Anti-infective Drugs Sales Market Share by Application (2020-2025)
Table 46. Europe Pets Anti-infective Drugs Sales by Company (2020-2025) & (K Units)
Table 47. Europe Pets Anti-infective Drugs Sales Market Share by Company (2020-2025)
Table 48. Europe Pets Anti-infective Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Pets Anti-infective Drugs Revenue Market Share by Company (2020-2025)
Table 50. Europe Pets Anti-infective Drugs Sales by Administration Method (2020-2025) & (K Units)
Table 51. Europe Pets Anti-infective Drugs Sales Market Share by Administration Method (2020-2025)
Table 52. Europe Pets Anti-infective Drugs Sales by Application (2020-2025) & (K Units)
Table 53. Europe Pets Anti-infective Drugs Sales Market Share by Application (2020-2025)
Table 54. China Pets Anti-infective Drugs Sales by Company (2020-2025) & (K Units)
Table 55. China Pets Anti-infective Drugs Sales Market Share by Company (2020-2025)
Table 56. China Pets Anti-infective Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Pets Anti-infective Drugs Revenue Market Share by Company (2020-2025)
Table 58. China Pets Anti-infective Drugs Sales by Administration Method (2020-2025) & (K Units)
Table 59. China Pets Anti-infective Drugs Sales Market Share by Administration Method (2020-2025)
Table 60. China Pets Anti-infective Drugs Sales by Application (2020-2025) & (K Units)
Table 61. China Pets Anti-infective Drugs Sales Market Share by Application (2020-2025)
Table 62. Brazil Pets Anti-infective Drugs Sales by Company (2020-2025) & (K Units)
Table 63. Brazil Pets Anti-infective Drugs Sales Market Share by Company (2020-2025)
Table 64. Brazil Pets Anti-infective Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 65. Brazil Pets Anti-infective Drugs Revenue Market Share by Company (2020-2025)
Table 66. Brazil Pets Anti-infective Drugs Sales by Administration Method (2020-2025) & (K Units)
Table 67. Brazil Pets Anti-infective Drugs Sales Market Share by Administration Method (2020-2025)
Table 68. Brazil Pets Anti-infective Drugs Sales by Application (2020-2025) & (K Units)
Table 69. Brazil Pets Anti-infective Drugs Sales Market Share by Application (2020-2025)
Table 70. Zoetis Company Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Zoetis Pets Anti-infective Drugs Product
Table 74. Zoetis Recent Development
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck Pets Anti-infective Drugs Product
Table 79. Merck Recent Development
Table 80. Elanco Company Information
Table 81. Elanco Description and Business Overview
Table 82. Elanco Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Elanco Pets Anti-infective Drugs Product
Table 84. Elanco Recent Development
Table 85. Virbac Company Information
Table 86. Virbac Description and Business Overview
Table 87. Virbac Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Virbac Pets Anti-infective Drugs Product
Table 89. Virbac Recent Development
Table 90. Dechra Veterinary Products Company Information
Table 91. Dechra Veterinary Products Description and Business Overview
Table 92. Dechra Veterinary Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Dechra Veterinary Products Pets Anti-infective Drugs Product
Table 94. Dechra Veterinary Products Recent Development
Table 95. Ceva Santé Animale Company Information
Table 96. Ceva Santé Animale Description and Business Overview
Table 97. Ceva Santé Animale Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Ceva Santé Animale Pets Anti-infective Drugs Product
Table 99. Ceva Santé Animale Recent Development
Table 100. Vetoquinol Company Information
Table 101. Vetoquinol Description and Business Overview
Table 102. Vetoquinol Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Vetoquinol Pets Anti-infective Drugs Product
Table 104. Vetoquinol Recent Development
Table 105. Nanjing Jindun Animal Company Information
Table 106. Nanjing Jindun Animal Description and Business Overview
Table 107. Nanjing Jindun Animal Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Nanjing Jindun Animal Pets Anti-infective Drugs Product
Table 109. Nanjing Jindun Animal Recent Development
Table 110. Wuhan Chopperlvya Company Information
Table 111. Wuhan Chopperlvya Description and Business Overview
Table 112. Wuhan Chopperlvya Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Wuhan Chopperlvya Pets Anti-infective Drugs Product
Table 114. Wuhan Chopperlvya Recent Development
Table 115. Bimeda Animal Health Company Information
Table 116. Bimeda Animal Health Description and Business Overview
Table 117. Bimeda Animal Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Bimeda Animal Health Pets Anti-infective Drugs Product
Table 119. Bimeda Animal Health Recent Development
Table 120. Ouro Fino Saude Company Information
Table 121. Ouro Fino Saude Description and Business Overview
Table 122. Ouro Fino Saude Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Ouro Fino Saude Pets Anti-infective Drugs Product
Table 124. Ouro Fino Saude Recent Development
Table 125. Norbrook Company Information
Table 126. Norbrook Description and Business Overview
Table 127. Norbrook Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Norbrook Pets Anti-infective Drugs Product
Table 129. Norbrook Recent Development
Table 130. Hanvet Pet Health Company Information
Table 131. Hanvet Pet Health Description and Business Overview
Table 132. Hanvet Pet Health Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Hanvet Pet Health Pets Anti-infective Drugs Product
Table 134. Hanvet Pet Health Recent Development
Table 135. Wuhan Hvsen Biotechnology Company Information
Table 136. Wuhan Hvsen Biotechnology Description and Business Overview
Table 137. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Wuhan Hvsen Biotechnology Pets Anti-infective Drugs Product
Table 139. Wuhan Hvsen Biotechnology Recent Development
Table 140. Zhejiang Hisun Animal Healthcare Products Company Information
Table 141. Zhejiang Hisun Animal Healthcare Products Description and Business Overview
Table 142. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Zhejiang Hisun Animal Healthcare Products Pets Anti-infective Drugs Product
Table 144. Zhejiang Hisun Animal Healthcare Products Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Pets Anti-infective Drugs Distributors List
Table 148. Pets Anti-infective Drugs Customers List
Table 149. Pets Anti-infective Drugs Market Trends
Table 150. Pets Anti-infective Drugs Market Drivers
Table 151. Pets Anti-infective Drugs Market Challenges
Table 152. Pets Anti-infective Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Pets Anti-infective Drugs Product Picture
Figure 2. Global Pets Anti-infective Drugs Sales (US$ Million) by Administration Method (2020 & 2024 & 2031)
Figure 3. Global Pets Anti-infective Drugs Sales Market Share by Administration Method in 2024 & 2031
Figure 4. External Use Product Picture
Figure 5. Internal Use Product Picture
Figure 6. Injection Product Picture
Figure 7. Global Pets Anti-infective Drugs Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Pets Anti-infective Drugs Sales Market Share by Application in 2024 & 2031
Figure 9. Dog Examples
Figure 10. Cat Examples
Figure 11. Others Examples
Figure 12. Global Pets Anti-infective Drugs Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pets Anti-infective Drugs Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Pets Anti-infective Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 15. Global Pets Anti-infective Drugs Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 16. Pets Anti-infective Drugs Report Years Considered
Figure 17. Global Market Pets Anti-infective Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Pets Anti-infective Drugs Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Pets Anti-infective Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Pets Anti-infective Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 21. Europe Pets Anti-infective Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Pets Anti-infective Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 23. China Pets Anti-infective Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Pets Anti-infective Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 25. Brazil Pets Anti-infective Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Brazil Pets Anti-infective Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 27. Global Pets Anti-infective Drugs Revenue Share by Administration Method (2020-2025)
Figure 28. Global Pets Anti-infective Drugs Sales Share by Administration Method (2026-2031)
Figure 29. Global Pets Anti-infective Drugs Revenue Share by Administration Method (2026-2031)
Figure 30. Global Pets Anti-infective Drugs Revenue Share by Application (2020-2025)
Figure 31. Global Pets Anti-infective Drugs Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Pets Anti-infective Drugs Sales Share by Application (2026-2031)
Figure 33. Global Pets Anti-infective Drugs Revenue Share by Application (2026-2031)
Figure 34. Global Pets Anti-infective Drugs Sales Share by Company (2024)
Figure 35. Global Pets Anti-infective Drugs Revenue Share by Company (2024)
Figure 36. Global 5 Largest Pets Anti-infective Drugs Players Market Share by Revenue in Pets Anti-infective Drugs: 2020 & 2024
Figure 37. Pets Anti-infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Pets Anti-infective Drugs
Figure 39. Manufacturing Process Analysis of Pets Anti-infective Drugs
Figure 40. Pets Anti-infective Drugs Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
